Analysed Guided Therapeutics Inc (GTHP:OTCMKTS) News Sources
Head and Neck Cancer Therapeutics Market to Reach USD 2.6 Billion by 2032, Driven by Immunotherapy and Precision Oncology - Credence Research Inc.
PR Newswire UK
Plus Therapeutics Inc.: Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ
FinanzNachrichten.de
TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development
Le Lézard
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates
Yahoo Finance Canada
What is the current price of Guided Therapeutics Inc (GTHP:OTCMKTS)?
The current price of Guided Therapeutics Inc (GTHP:OTCMKTS) is $0.37.
Guided Therapeutics Inc (GTHP:OTCMKTS) absolute price change since previous trading day?
The absolute price change of Guided Therapeutics Inc (GTHP:OTCMKTS) since the previous trading day is $0.07.
Guided Therapeutics Inc (GTHP:OTCMKTS) percentage price change since previous trading day?
The percentage price change of Guided Therapeutics Inc (GTHP:OTCMKTS) since the previous trading day is 23.33%.
What is This Week's average sentiment score for Guided Therapeutics Inc (GTHP:OTCMKTS)?
This Week's average sentiment score for Guided Therapeutics Inc (GTHP:OTCMKTS) is 81 out of 100.
What is This Week's average sentiment for Guided Therapeutics Inc (GTHP:OTCMKTS)?
This Week's sentiment for Guided Therapeutics Inc (GTHP:OTCMKTS) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.